Next-generation rapid phenotypic antimicrobial susceptibility testing
12 November 2024
This Review synthesizes publications and submissions on next-generation rapid antimicrobial susceptibility testing (AST) technologies, analyzing over 90 technologies in terms of technical innovations, readiness level, clinical validation, and time-to-results. It provides a guide for developers and clinical microbiologists.
Further reading: Nature Communications
Author(s): Grace Reszetnik et al
Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!